Here are the S-1 registration statements from Tessera Defense and Homeland Security Inc. (HLSQ) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow HLSQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLSQ filings page.
BiomX Inc. is registering 7,163,000 shares of common stock for resale by selling stockholders. The shares include 2,223,000 already issued shares, 4,615,000 shares underlying warrants and up to 325,000 shares issuable upon conversion of a $3,000,000 note. BiomX will not receive proceeds from resales, only potential cash from warrant exercises.
The shares were issued as consideration for two April 2026 acquisitions, Water IO (Zorronet) and Mandragola (DFSL), as part of a strategic pivot from phage therapies to defense, security and critical infrastructure technologies. The company highlights that full issuance could significantly dilute existing holders.
BiomX faces substantial risks: a going concern qualification, a stockholders’ deficit, NYSE American continued listing deficiencies with a remediation plan through September 25, 2027, high dependence on new Israeli defense subsidiaries and complex earnout and bonus obligations tied to Zorronet and DFSL performance.